Format

Send to

Choose Destination
J Virol. 2016 Feb 26;90(6):3276-7. doi: 10.1128/JVI.02970-15. Print 2016 Mar.

Reply to "The Broadly Neutralizing, Anti-HIV Antibody 4E10: an Open and Shut Case?".

Author information

1
Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan Biophysics Unit (CSIC, UPV/EHU) and Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), Bilbao, Spain.
2
Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.
3
Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.
4
Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
5
Biophysics Unit (CSIC, UPV/EHU) and Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), Bilbao, Spain joseluis.nieva@ehu.es jose@bioeng.t.u-tokyo.ac.jp.
6
Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan joseluis.nieva@ehu.es jose@bioeng.t.u-tokyo.ac.jp.
PMID:
26921373
PMCID:
PMC4810630
DOI:
10.1128/JVI.02970-15
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center